References
- Asai K, Funai C, Hayashi T, Yamada K, Naito M, Kuzuya M, Yamada K, Yoshimine N, Kuzuya F. Dexamethasone-induces suppression of aortic atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb 1993; 13: 892–899
- Branford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254
- Chono S, Tauchi Y, Deguchi Y, Morimoto K. Efficient drug delivery to atherosclerotic lesions and the antiatherosclerotic effect by dexamethasone incorporated into liposomes in atherogenic mice. J Drug Target 2005, in press
- Hatch F, Less RS. Practical methods for plasma lipoprotein analysis. Adv Lipid Res 1968; 6: 2–63
- Igarashi R, Takenaga M, Takeuchi J, Kitagawa A, Matsumoto K, Mizushima Y. Marked hypotensive and blood flow-increasing effects of a new lipo-PGE(1) (lipo-AS013) due to vascular wall targeting. J Control Release 2001; 71: 157–164
- Makheja AN, Bloom S, Muesing R, Simon TM, Bailey JM. Anti-inframmatory drugs in experimental atherosclerosis: 4. Inhibition of atherosclerosis in vivo and thromboxane synthesis and platelet aggregation in vivo. Atherosclerosis 1989; 76: 155–161
- Mizushima Y, Hamano T, Yokoyama K. Tissue distribution and anti-inframmatory activity of corticosteroids incorporated in lipid emulsion. Ann Rheum Dis 1982; 41: 263–267
- Mizushima Y, Hoshi K. Review: Recent advances in lipid microsphere technology for targeting prostaglandin delivery. J Drug Target 1993; 1: 93–100
- Naito M, Yasue M, Asai K, Yamada K, Hayashi T, Kuzuya M, Funai C, Yoshimine N, Kuzuya F. Effect of dexamethasone on experimental atherosclerosis in cholesterol-fed rabbits. J Nutr Sci Vitaminol 1992; 38: 255–264
- Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801–809
- Ross R. Atherosclerosis-an inframmtory disease. N Engl J Med 1999; 340: 115–126
- Ryu BH, Mao FW, Lou P, Gutman RL. Cholesterol ester accumulation in macrophages treated with oxidized low density lipoprotein. Biosci Biotech Biochem 1995; 59: 1619–1622
- Takenaga M, Igarashi R, Tsuji H, Mizushima Y. Enhanced antitumor activity and reduced toxicity of 1, 3-bis(2-chloroethyl)-1-nitrosourea administered in lipid microspheres to tumor-bearing mice. Jpn J Cancer Res 1993a; 84: 1078–1085
- Takenaga M, Nakagawa T, Igarashi R, Mizushima Y. Application of lipid microspheres to prepare a thromboxane A2 receptor antagonist aerosol for inhalation. J Drug Target 1993b; 1: 293–301
- Tauchi Y, Takase M, Zushida I, Chono S, Sato J, Ito K, Morimoto K. Preparation of a complex of dexamethasone palmitate-low density lipoprotein and its effect on foam cell formation of murine peritoneal macrophages. J Pharm Sci 1999; 88: 709–714
- Tauchi Y, Takase M, Zushida I, Yokota M, Chono S, Sato J, Ito K, Morimoto K. Inhibitory effect of dexamethasone palmitate-low density lipoprotein complex on low density lipoprotein-induced macrophage foam cell formation. Biol Pharm Bull 2000; 23: 466–471
- Tauchi Y, Zushida I, Chono S, Sato J, Ito K, Morimoto K. Effect of dexamethasone palmitate-low density lipoprotein complex on cholesterol ester accumulation in aorta of atherogenic model mice. Biol Pharm Bull 2001; 24: 925–929
- Tauchi Y, Yoshimi A, Shirahase H, Sato J, Ito K, Morimoto K. Inhibitory effect of acyl-CoA: Cholesterol acyltransferase inhibitor-low density lipoprotein complex on experimental atherosclerosis. Biol Pharm Bull 2003; 26: 73–78
- Tedgui A, Bernard C. Cytokines, immuno-inframmatory response and atherosclerosis. Eur Cytokine Network 1994; 5: 263–270
- Van Put DJM, Van Hove CE, De Meyer GRY, Wuyts F, Herman AG, Bult H. Dexamethasone influences intimal thickening and vascular reactivity in the rabbit collared carotid artery. Eur J Pharmacol 1995; 294: 753–761
- Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherosclerosis. J Clin Investig 1991; 88: 1785–1792
- Yamaguchi T, Mizushima Y. Lipid microsphere for drug delivery from the pharmaceutical viewpoint. Crit Rev Ther Drug Carrier Syst 1994; 11: 215–229
- Yamaguchi Y, Kitagawa S, Imaizumi N, Kunitomo M, Fujiwara M. Enhancement of aortic cholesterol deposition by dietaary linoleic acid in cholesterol-fed mice: An animal model for primary screening of antiatherosclerotic agents. J Pharmacol Toxicol Methods 1993; 30: 169–175
- Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabit and man. J Clin Investig 1989; 84: 1086–1095